drugset / Trial / NCT03660943
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, 2-injection, 52-week study to evaluate the efficacy and safety of intra-articular injections of CNTX-4975-05 in subjects with chronic, moderate-to-severe osteoarthritis knee pain.
Timeline
- Start
- 2018-09-09
- Primary completion
- 2020-06-11
- Completion
- 2020-06-11
Outcome
Missed primary endpoint
registry analysis (superiority test); Placebo vs CNTX-4975-05; p = 0.0833; Mean Difference (Final Values) -2.07 (95% CI -4.42 to 0.27) NCT03660943 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CNTX-4975-05 | Unknown | 2 ml | Other |